Stay updated on GEN-009 Vaccine Safety, Immunogenicity in Clinical Trial
Sign up to get notified when there's something new on the GEN-009 Vaccine Safety, Immunogenicity in Clinical Trial page.

Latest updates to the GEN-009 Vaccine Safety, Immunogenicity in Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2 on the page header, with no changes to study details, eligibility, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedRemoved the government funding operating-status notice from the page.SummaryDifference0.3%

- Check42 days agoChange DetectedNo additions or deletions to core study content observed; the title, conditions, eligibility criteria, enrollment, and locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedUpgrade notice added: new government funding lapse notice with operating status and official sources; version updated from v3.1.0 to v3.2.0.SummaryDifference3%

- Check78 days agoChange DetectedRenaming a medical condition to a more precise term and updating versioning from v3.0.2 to v3.1.0; older terms and unrelated melanoma entry removed.SummaryDifference0.8%

- Check92 days agoChange DetectedUpdated from v3.0.1 to v3.0.2, indicating a minor update. The Back to Top element was removed, while core content and pricing remain unchanged.SummaryDifference0.2%

Stay in the know with updates to GEN-009 Vaccine Safety, Immunogenicity in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEN-009 Vaccine Safety, Immunogenicity in Clinical Trial page.